Adaptive Biotechnologies (ADPT) Goodwill (2018 - 2026)

Adaptive Biotechnologies has reported Goodwill for 9 years, with the latest figure at $119.0 million in Q1 2026.

• Quarterly Goodwill changed 0.0% year-over-year to $119.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $119.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $119.0 million, changed 0.0% from the prior year.
• Goodwill was little changed at $119.0 million in Q1 2026 per ADPT's latest filing, from $119.0 million in the prior quarter.
• Over five years, Goodwill peaked at $119.0 million in Q1 2022 and troughed at $119.0 million in Q1 2022.
• A 5-year average of $119.0 million and a median of $119.0 million in 2022 frame the typical range for Goodwill.
• The widest YoY moves for Goodwill: up 0.0% in 2022, down 0.0% in 2022.
• Over 5 years, Goodwill stood at $119.0 million in 2022, then changed by 0.0% to $119.0 million in 2023, then changed by 0.0% to $119.0 million in 2024, then changed by 0.0% to $119.0 million in 2025, then changed by 0.0% to $119.0 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $119.0 million, $119.0 million, and $119.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.